All Blogs / Health / Diseases & Conditions / Multiple Sclerosis / Popular

Stimulating Neurons to Help with Problem-Solving

One of the most troubling symptoms of multiple sclerosis, especially for those of us who are still working, is “brain fog” — not being able to concentrate … not feeling “sharp” when working on a task or solving problems. So I was interested...Show More Summary

#ACTRIMS2017 – High Salt Diet Seen as Potential Risk Factor for MS in New Study

New evidence strengthens the link between a diet high in salt and multiple sclerosis (MS) development, researchers show. The study, “Sodium Chloride Intake and MS,” was presented on Feb. 24 at the ACTRIMS) 2017 Forum being held in Orlando, Florida, by Dr. Show More Summary

#ACTRIMS2017 – 3 Trials Show MS Patients Receiving Ocrevus Had No Elevated Infection Risk

A detailed analysis of relapsing and primary progressive multiple sclerosis (MS) patients in the three Phase 3 trials of Ocrevus (ocrelizumab) showed that the treatment did not significantly increase their risk of infections — serious or otherwise. Show More Summary

#ACTRIMS2017 – Some Fatty Acids in Diet Help, Others Hurt Immune System, Study Reports

Short-chain dietary fatty acids, such as propionate, drive the production of regulatory immune T-cells in patients with multiple sclerosis (MS), while long-chain acids promote T-cells that are involved in inflammatory processes. Since...Show More Summary

#ACTRIMS2017 – Sun Exposure May Lower Fatigue, Slow Disability Progression in MS

Spending more time in the sunshine could make people with multiple sclerosis (MS) feel more energetic, though dietary vitamin D intake’s effect is mixed, depending on what type of MS a particular patient has. That’s the conclusion of...Show More Summary

6 Foods That Can Help You Fight a Cold or Flu

Winter is a perilous time if you have a compromised immune system, but you can’t stay alone inside for four months. You have to get on with your daily life, and just hope you don’t succumb to other people’s bugs and illnesses. However,...Show More Summary

#ACTRIMS2017 – Lemtrada Maintains Durable Positive Effects in MS Without Additional Treatment

Two Phase 3 clinical trials investigating the long-term effects of Lemtrada (alemtuzumab) in multiple sclerosis (MS) patients showed the drug maintained improved outcomes, even in the absence of further treatment. Both studies were presented at the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) 2017 Forum, held Feb. Show More Summary

#ACTRIMS2017 – No Evidence of Progression More Likely Among PPMS Patients on Ocrevus

Genentech’s Ocrevus (ocrelizumab) increased the proportion of patients with no evidence of progression (NEP) in the recently concluded ORATORIO Phase 3 clinical trial in patients with primary progressive multiple sclerosis (PPMS). The...Show More Summary

#ACTRIMS2017 – Learning is Underway at Annual MS Confab

Editor’s note: Columnist Laura Kolaczkowski reports from ACTRIMS in Orlando, Fla. The second Annual Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) got under way in Orlando, Fla., today and runs through Saturday. Show More Summary

#ACTRIMS2017 – Early MS Evidence Found in Asymptomatic First-degree Relatives of Patients

First-degree relatives of multiple sclerosis (MS) patients may develop asymptomatic disease, suggesting the need to further evaluate family members to develop timely prevention strategies. The study, “Investigating early evidence ofShow More Summary

#ACTRIMS2017 – Airway Infections May Be More Common in MS Due to Altered Immune Response in Lungs

Disease processes in multiple sclerosis (MS) likely contribute to the increased sensitivity to airway infections seen in MS patients, a series of experiments in mice demonstrated. The study, presented at the ACTRIMS 2017 Forum, showed...Show More Summary

MS is No Excuse for Being Discourteous When Offered Help

It was a trip, plain and simple, neither my leg giving way nor a fall. It was MS-related because it was directly caused by foot drop; the toe of my left shoe caught on the tiniest ridge at the bottom of a ramp. My trip wasn’t dramatic, I didn’t end up on my face. Show More Summary

MS treatment that 'resets' immune system may halt disease progression for at least 5 years

A type of treatment for multiple sclerosis that 'resets' the immune system may stop progression of the disease in nearly half of patients. In a new study, the treatment prevented symptoms of severe disease from worsening for five years, in 46 percent of patients.

#ACTRIMS2017 – This Year’s Hot Topics

Editor’s choice: Patrícia Silva holds her PhD in Medical Microbiology and Infectious Diseases from the Leiden University Medical Center in Leiden, The Netherlands. She has studied Applied Biology at Universidade do Minho and was a postdoctoral research fellow at Instituto de Medicina Molecular in Lisbon, Portugal. Show More Summary

Brazil Allows HempMeds to Import RSHO Cannabidiol for MS Treatment

The Brazilian government has authorized HempMeds Brasil, a unit of California-based Medical Marijuana, to import the parent company’s hemp cannabidiol (CBD) oil flagship product — known as Real Scientific Hemp Oil (RSHO) — for the management of multiple sclerosis (MS) symptoms. Show More Summary

Compound ozanimod shows positive results in late-stage clinical trial for relapsing multiple sclerosis

Ozanimod, a drug candidate can reduce the frequency of multiple sclerosis relapse, results from a new Phase 3 study demonstrate.

Unaware of All the Invisible Things

I spent my twenties angry that my thighs were not thinner and my abs were not flatter. Sometimes I try to calculate how many hours of untapped imagination was wasted in that decade. Time I could have spent exploring my world instead of agonizing over my perfectly healthy body. Show More Summary

How to Survive an MRI If You are Claustrophobic

A key test for identifying multiple sclerosis during diagnosis, or to confirm a relapse, is magnetic resonance imaging (MRI.) For those who’ve never had to undergo an MRI, the thought of having this test might be terrifying. Being encased...Show More Summary

Travel Plans Actually Require Planning These Days, Thanks to MS

In my younger years, I took great pride in my far-flung spontaneity, and unfairly judged those I perceived to be too thoughtful and prudent. Age, with its attendant wisdom and experience, moved me slightly inland. In 2003, MS arrived...Show More Summary

Apitope’s ATX-MS-1468 Therapy Decreases Brain Lesions in Relapsing MS Patients

Treatment with Apitope’s lead agent, ATX-MS-1467, decreased brain lesions in patients with relapsing multiple sclerosis (MS) in a now-completed Phase 2a clinical trial. ATX-MS-1467 is a potential disease-modifying agent with an immune-tolerating action. Show More Summary

Copyright © 2015 Regator, LLC